FDA Device Intelligence
Home › Siemens Healthcare Diagnostics Inc. › ADVIA® Chemistry Total Bilirubin_2 TBIL_2 Reagents

ADVIA® Chemistry Total Bilirubin_2 TBIL_2 Reagents

Siemens Healthcare Diagnostics Inc. · Model 10341113 · UDI-DI 00630414513058

MQMJFM
2
510(k) clearances
72
Adverse events (1 deaths)
6
Recalls
39
Facilities

Description

Bilirubin Total - ADVIA Chem. - RGT - 4x672 tests

Recalls

DateFirmReason
2018-05-15Draeger Medical Systems, Inc.Users have misinterpreted the display for out of range measurement indicated by the blinking" ---" to mean a zero measurement.
2018-05-15Draeger Medical Systems, Inc.Users have misinterpreted the display for out of range measurement indicated by the blinking "-0-" to mean a zero measurement
2014-12-30Siemens Healthcare Diagnostics IncNeonatal bilirubin (nBili) parameter may have increased variability when the nBili concentration is greater than 12 mg/dl and the tHb concentration exceeds the upper reportable ran
2014-12-30Siemens Healthcare Diagnostics IncNeonatal bilirubin (nBili) parameter may have increased variability when the nBili concentration is greater than 12 mg/dl and the tHb concentration exceeds the upper reportable ran
2014-12-30Siemens Healthcare Diagnostics IncNeonatal bilirubin (nBili) parameter may have increased variability when the nBili concentration is greater than 12 mg/dl and the tHb concentration exceeds the upper reportable ran
2014-12-30Siemens Healthcare Diagnostics IncNeonatal bilirubin (nBili) parameter may have increased variability when the nBili concentration is greater than 12 mg/dl and the tHb concentration exceeds the upper reportable ran

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.